Pavel Khrimian, MBA

Associate Director, Partnering & Strategy at MedImmune (A Member of the AstraZeneca Group)

A global strategic bio-pharmaceutical professional specializing in the development of external collaborations focused on a wide range of services and technologies from early discovery research to commercialization that help drive a R&D and Commercial pipeline, as well as Diagnostics and Digital Health.